Trials / Conditions / Adenocarcinoma of Prostate

Adenocarcinoma of Prostate

11 registered clinical trials studyying Adenocarcinoma of Prostate.

Status	Trial	Sponsor	Phase
Active Not Recruiting	Multimodal Machine Learning Characterization of Solid Tumors NCT04687969	Ciprian Catana, MD, PhD	—
Unknown	Carbon Ions Boost Followed by Pelvic Photon Radiotherapy for High Risk Prostate Cancer NCT02672449	European Institute of Oncology	N/A
Completed	Devel. and Eval. of an Active Surveillance Decision Aid for Men With Low or Intermediate Grade Prostate Cancer NCT02342626	University of Rochester	N/A
Unknown	HDR vs LDR Brachytherapy as Monotherapy in the Treatment of Localized Prostate Cancer. NCT02258087	National Institute of Oncology, Hungary	Phase 2 / Phase 3
Unknown	Short-term High Precision Radiotherapy for Early Prostate Cancer With Concomitant Boost on the Dominant Lesion NCT01913717	European Institute of Oncology	N/A
Completed	Short Course Radiotherapy for Localized Prostate Cancer NCT03518853	Tata Medical Center	N/A
Active Not Recruiting	A Phase III of Cabazitaxel and Pelvic Radiotherapy in Localized Prostate Cancer and High-risk Features of Rela NCT01952223	UNICANCER	Phase 3
Terminated	Treatment Decision Analysis Model for Prostate Cancer: A Randomized Trial NCT02024685	Case Comprehensive Cancer Center	N/A
Active Not Recruiting	Comparison of HT Concomitant With RT vs RT Alone in Patients With a Detectable PSA After Prostatectomy NCT01994239	UNICANCER	Phase 2
Completed	Impact of Local Anesthesia Type on Cancer Detection Rate in Transrectal Ultrasound Guided Prostate Biopsy NCT02025361	Bagcilar Training and Research Hospital	Phase 4
Completed	Mifepristone (RU-486) in Androgen Independent Prostate Cancer NCT00140478	Dana-Farber Cancer Institute	Phase 2